As a critical member of the protein disulfide isomerase (PDI) family, the aberrant overexpression of TXNDC5 protein has been investigated in multiple human tumors, including esophageal squamous cell carcinoma (48), cervical cancer (49), lung cancer (50), and hepatocellular carcinoma (51). Here, TXNDC5 is linked to hepatocellular carcinoma.